Mettler-Toledo International Inc. Common Stock (MTD)
Stock · NYSE · Industrials
$1,399as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1,249
Industry
Biotechnology: Laboratory Analytical Instruments
About MTD
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators,…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 16,600
- Website
- www.mt.com
Fundamentals
- 1-day range
- $1,403$1,424
- Market cap
- $28.48B
- P/E (trailing)
- 31.95
- P/E (forward)
- 27.45
- EPS (trailing)
- $44.42
- Dividend yield
- —
- Beta
- 1.22
- Avg. volume
- 199.3K
52-week range
$1,023$1,525
Next earnings: November 5, 2026 · EPS estimate $12.11After Closeconfirmed
How Mettler-Toledo International Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 6, 2026 · via SEC EDGAR / Finnhub
Forecasts
11 analyst ratings
Buy 42%
Hold 50%
Sell 8%
1-year price forecast
High
$1,600
+14.4%
Median
$1,458
+4.2%
Low
$1,200
-14.2%
Mettler-Toledo International Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MTDMettler-Toledo International Inc. Common Stock$1,399▼ 0.63%Market cap $28.48BP/E 31.95$1,023$1,525
- RVTYRevvity Inc. Common Stock$128.8▼ 0.70%Market cap $12.74BP/E 55.10$81.22$129.8
- TXG10x Genomics Inc. Class A Common Stock$61.55▼ 5.10%Market cap $5.79BP/E —$11.16$66.94
- EYPTEyePoint Inc. Common Stock$4.47▼ 3.46%Market cap $1.08BP/E —$3.95$19.11
- CTKBCytek Biosciences Inc. Common Stock$4.69▲ 1.41%Market cap $537.23MP/E —$3.28$6.18
- PACBPacific Biosciences of California Inc. Common Stock$1.4▼ 10.00%Market cap $361.85MP/E —$1.07$2.73
- QTRXQuanterix Corporation Common Stock$2.64▼ 0.00%Market cap $180.42MP/E —
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MTD Mettler-Toledo International Inc. Common Stock | $28.48B | 31.95 | $1,399 | ▼ 0.63% | $1,023$1,525 |
| RVTY Revvity Inc. Common Stock | $12.74B | 55.10 | $128.8 | ▼ 0.70% | $81.22$129.8 |
| TXG 10x Genomics Inc. Class A Common Stock | $5.79B | — | $61.55 | ▼ 5.10% | $11.16$66.94 |
| EYPT EyePoint Inc. Common Stock | $1.08B | — | $4.47 | ▼ 3.46% | $3.95$19.11 |
| CTKB Cytek Biosciences Inc. Common Stock | $537.23M | — | $4.69 | ▲ 1.41% | $3.28$6.18 |
| PACB Pacific Biosciences of California Inc. Common Stock | $361.85M | — | $1.4 | ▼ 10.00% | $1.07$2.73 |
| QTRX Quanterix Corporation Common Stock | $180.42M | — | $2.64 | ▼ 0.00% |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Mettler-Toledo (MTD) Upgraded to Buy: Here's WhyYahoo · 8/21/2026
- 1 Healthcare Stock to Target This Week and 2 Facing HeadwindsYahoo · 8/20/2026
- Beat the Market the Zacks Way: Bank of America, Marex, Mettler-Toledo International in FocusYahoo · 8/17/2026
- What Investors Should Know About a Mettler-Toledo Director's Two Transactions This Past WeekYahoo · 8/10/2026
- What Investors Should Know as Mettler-Toledo Insiders Sell Shares After a Strong QuarterYahoo · 8/10/2026
- A Mettler-Toledo Director Sold $600,000 in Stock. Here's What Investors Should KnowYahoo · 8/10/2026
- Mettler-Toledo's CFO Cashed In Options After a Strong Quarter. Here's What to KnowYahoo · 8/10/2026
- 2 Mid-Cap Stocks to Target This Week and 1 Facing HeadwindsYahoo · 8/10/2026
Insider Activity
Insider Actions →Acquired
6.9K
Disposed
2.9K
- Thomas P. Salice · August 3, 2026 · Option Exercise415 @ $397.95
- Thomas P. Salice · August 3, 2026 · Sale415 @ $1,445
- Gerry Keller · August 3, 2026 · Option Exercise240 @ $720.81
- Gerry Keller · August 3, 2026 · Sale240 @ $1,427
- Shawn Vadala · August 3, 2026 · Option Exercise2.2K @ $595.31
- Shawn Vadala · August 3, 2026 · Sale2.2K @ $1,432
- Ann Ping Richard Wong · May 12, 2026 · Grant255
- Ann Ping Richard Wong · May 12, 2026 · Grant103
- Oliver Wittorf · May 12, 2026 · Grant215
- Oliver Wittorf · May 12, 2026 · Grant87
- Shawn Vadala · May 12, 2026 · Grant720
- Shawn Vadala · May 12, 2026 · Grant291
- Gerry Keller · May 12, 2026 · Grant250
- Gerry Keller · May 12, 2026 · Grant100
- Patrick Kaltenbach · May 12, 2026 · Grant2.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 18.67M
- Total value held
- $21.99B
- Institutional holders
- 811
Top holders this quarter
- Unknown1.77M
- Unknown1.32M
- Unknown1.08M
- Unknown942.5K
- Unknown757.1K
- Unknown732.1K
- Unknown703.5K
- Unknown605.7K
- Unknown568.5K
- Unknown488.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 28, 2026
Mettler-Toledo Upgraded by Analyst Citing Valuation Case. Mettler-Toledo (MTD) was upgraded by an analyst, with coverage pointing to a more constructive view of the stock's valuation setup. The upgrade comes as the shares trade well below their 52-week high of $1525.17 and sit near a support level around $1287 that has been tested multiple times. The average analyst price target stands at about $1469, above the recent trading area, which the upgrade reflects. The note frames the case around the stock's risk profile relative to its historical range rather than any single new earnings catalyst.